NCT04624165

Brief Summary

Research question: do patients in a gynecologic oncology practice value the use of telemedicine as an adjunct to in-person visits and in what circumstances might patients not find these visits to be sufficient?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
116

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

November 10, 2020

Completed
2 months until next milestone

Study Start

First participant enrolled

January 21, 2021

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2021

Completed
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 24, 2022

Completed
Last Updated

August 8, 2023

Status Verified

August 1, 2023

Enrollment Period

6 months

First QC Date

October 26, 2020

Last Update Submit

August 3, 2023

Conditions

Oncology

Keywords

Telemedicine

Outcome Measures

Primary Outcomes (1)

  • Patient's perspective on telemedicine on a Likert Scale

    Patient's perspective on telemedicine on a Likert Scale

    Through survey completion, an average of 15 minutes

Interventions

SurveyOTHER

o We plan to hand out copies of a survey to examine patient's perspective on telemedicine.

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

o Eligible patients would be at least 18 years of age, and currently being treated by one of the providers within the gynecologic oncology group.

o Eligible patients would be at least 18 years of age, and currently being treated by one of the providers within the gynecologic oncology group.

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

TriHealth - Good Samaritan and Bethesda North Hospitals

Cincinnati, Ohio, 45220, United States

Location

MeSH Terms

Conditions

Neoplasms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Robert Neff, MD

    TriHealth Inc.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 26, 2020

First Posted

November 10, 2020

Study Start

January 21, 2021

Primary Completion

July 30, 2021

Study Completion

October 24, 2022

Last Updated

August 8, 2023

Record last verified: 2023-08

Data Sharing

IPD Sharing
Will not share

Locations

US(1)